Largest single-institution series of robotic pneumonectomy - Report - MDSpire

Largest single-institution series of robotic pneumonectomy

  • By

  • Ammar Asban

  • Nikolaos Pachos

  • Caroline A. Snyder

  • Isabella Ferraro

  • Stephanie Chang

  • Costas Bizekis

  • Robert J. Cerfolio

  • Michael D. Zervos

  • June 24, 2026

  • 0 min

Share

Clinical Report: Comprehensive Analysis of the Largest Consecutive Robotic Pneumonectomy Series

Background

Robotic pneumonectomy remains underutilized. The procedure is particularly relevant for patients with complex conditions such as advanced lung cancer and those who have undergone neoadjuvant therapies. Understanding the outcomes of robotic pneumonectomy can help inform surgical practices and patient management strategies.

Data Highlights

ParameterValue
Number of Patients21
Median Age70
30-Day Readmission Rate19%
30-Day Morbidity19%
90-Day Mortality5%

Key Findings

  • Robotic pneumonectomy was performed on 21 patients, with 67% being male.
  • The median age of patients was 70 years, with a range of 15 to 79 years.
  • Indications for surgery included cancer in 81% of cases, primarily lung cancer.
  • Neoadjuvant therapy was administered to 76% of cancer patients.
  • The median length of hospital stay was five days, with a range of 1 to 25 days.
  • No intraoperative transfusions were required, and 30-day mortality was 0%.

Clinical Implications

The findings suggest that robotic pneumonectomy can be safely performed in high-risk patients, with minimal conversion to open surgery and no need for blood transfusions. These outcomes may encourage broader adoption of robotic techniques in thoracic surgery.

Conclusion

Robotic pneumonectomy demonstrates promising short-term outcomes and can be considered a viable option for patients requiring this complex surgical intervention.

Related Resources & Content

  1. Frontiers in Surgery, 2026 -- Outcomes of robotic anatomic lung resection after neoadjuvant therapy for non-small cell lung cancer
  2. Surgical Endoscopy, 2025 -- Evaluation of the Learning Curve in 100 Successive Robotic Liver Resections
  3. Surgical Endoscopy, 2021 -- Comparison of Robotic and Laparoscopic Techniques in Liver Surgery: Insights from a Six-Year Study of 600 Patients at a Single Institution
  4. NCCN Guidelines lung Cancer Version 2.2026
  5. Non-Small Cell Lung Cancer Treatment (PDQ®) - NCI
  6. Updates in Surgery — Innovative Robotic Approaches to Hepatectomy and Biliary Reconstruction in Perihilar Cholangiocarcinoma: A Groundbreaking Case Series from the West
  7. European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer
  8. NCCN Guidelines lung Cancer Version 2.2026
  9. Non-Small Cell Lung Cancer Treatment (PDQ®) - NCI
  10. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) | European Respiratory Society
  11. WTSA - Largest Single Institution Series of Robotic Pneumonectomy
  12. Frontiers | Outcomes of robotic anatomic lung resection after neoadjuvant therapy for non-small cell lung cancer
  13. Robotic-assisted thoracic surgery for resectable lung cancer: efficacy, safety and surgical approaches — an umbrella review of meta-analyses | BMC Surgery | Springer Nature Link

Original Source(s)

Related Content